Understanding how chemical changes in RNA affect uterine fibroids
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids
This study is looking at how a certain chemical change in RNA might affect the growth of uterine fibroids, which are non-cancerous tumors that can cause problems for women, with the goal of finding new, gentle treatment options for those dealing with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11094063 on NIH RePORTER |
What this research studies
This research investigates the role of a specific chemical modification in RNA, known as m6A, in the development of uterine fibroids, which are non-cancerous tumors affecting women's health. The study aims to uncover the underlying mechanisms of how these modifications contribute to the growth and behavior of fibroids. By analyzing the expression of m6A-related proteins in fibroid tissues, the researchers hope to identify potential therapeutic targets that could lead to new, non-invasive treatment options for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with uterine fibroids who are seeking alternative treatment options.
Not a fit: Patients who do not have uterine fibroids or those who are not experiencing symptoms related to this condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for uterine fibroids, improving the quality of life for many women.
How similar studies have performed: While the specific approach of targeting m6A in uterine fibroids is novel, similar research has shown promise in other conditions, indicating potential for success.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Boyer, Thomas G — University of Texas Hlth Science Center
- Study coordinator: Boyer, Thomas G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.